Here are the top 5 soft tissue sarcoma articles of 2025: ...
The survival prospects for children and adolescents with cancer in China have improved markedly, with the overall five-year ...
GlobalData on MSN
MSD begins KANDLELIT-007 trial of calderasib for NSCLC
Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.
Immunome, Inc. (NASDAQ: IMNM) is one of the stocks Jim Cramer offered insights on. When a caller inquired about the stock, ...
The therapy is a highly advanced form of radiation therapy that uses charged particles in the form of a proton that that gets ...
Rathbun, Peters, Clites and other researchers at UCLA expressed relief at having their funding restored. But because the ...
Under a law taking effect Jan. 1, California seeks to uphold the labor and unionization rights of private-sector employees, ...
Pivotal Phase 3 trial of MO-03 builds on prior studies that demonstrated enhanced immunotherapy benefit without added ...
Glomus tumours are uncommon, typically benign neoplasms of specialised dermal thermoregulatory structures known as glomus ...
Elena Elimova, MD, shares efficacy data for zanidatamab in patients with HER2-positive gastroesophageal adenocarcinoma from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results